Shortage Watch Free FDA drug-shortage watch

← all medications

Piperacillin and Tazobactam Injection

Category: Anti-Infective

Not specified 1

FDA status: To Be Discontinued · Last FDA update: Jan 20, 2026 · First posted: Jan 20, 2026 · 1 manufacturers, 1 listed presentations

As of Jan 20, 2026, the FDA lists Piperacillin and Tazobactam Injection as being discontinued. Of 1 manufacturer presentations, 1 Not specified.

Ask your pharmacist: which of the 1 manufacturers below can they order right now, and whether a different strength or form of Piperacillin and Tazobactam Injection is available. For alternatives, talk to your prescriber — see what to do if your medication is in shortage.
Presentation & package NDCManufacturerAvailabilityFDA note
Piperacillin and Tazobactam, Injection, 2.25 g vial (NDC 65219-434-20)
NDC 65219-434-20
Fresenius Kabi USA, LLC Not specified Discontinuation of the manufacture of the drug

Related medications in shortage

Other Anti-Infective medications currently on the FDA shortage list — useful context if you and your prescriber are weighing alternatives. Always confirm with your pharmacist.

Change log

No changes recorded yet.
Tracking began Oct 1, 2026. We check the FDA every 6 hours; any real change - a manufacturer moving from Limited to Available, a new recovery date, a new listing - shows up here with its date.

Cite this: “FDA drug-shortage status for Piperacillin and Tazobactam Injection (FDA data as of Jan 20, 2026). Shortage Watch, openFDA.”

Get an email when this record changes

One email, only when the FDA changes something for Piperacillin and Tazobactam Injection. You confirm by clicking a link first (double opt-in). No newsletter, no other mail.

Check your inbox - click the confirmation link to activate alerts for Piperacillin and Tazobactam Injection.

Feeds instead of email: RSS or JSON. Unsubscribe anytime; see Privacy.

Embed a live status badge: /badge/piperacillin-and-tazobactam-injection.svg

FDA data last synced Oct 1, 2026 (FDA record dated Sep 30, 2026).